Regeneron Pharmaceuticals, Inc. (0R2M)
LSE
Closed
Oct 9, 2026
Day's Range
730.3352 wk Range
541.00Overview - 0R2M - Regeneron Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
68.31B
P/E (Trailing)
‪0.10‬
PEG Ratio
‪0.0066‬
Price / Sales (TTM)
‪684.51‬
Price / Book
‪2.33‬
EV / EBITDA
‪14.52‬
Profitability
Profit Margin
‪27.86%‬
Operating Margin
‪33.10%‬
Return on Assets
‪6.52%‬
Return on Equity
‪14.04%‬
Ownership
Shares Outstanding
108.03M
Float
95.84M
Held by Insiders
‪2.08%‬
Held by Institutions
‪93.54%‬
Price stats
Beta
‪0.19‬
50-Day Avg
‪947.92‬
200-Day Avg
‪834.06‬
Dividends
Frequency
Quarterly
Market Cap - 0R2M - Regeneron Pharmaceuticals, Inc.
Peers - 0R2M - Regeneron Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0R2MLSERegeneron Pharmaceuticals, Inc.79.08BMarket Cap+20.99%52-week change0.11P/E (Trailing)‪27.86%‬Profit Margin
- 0MGBLSEGenmab A/S198.39BMarket Cap+15.12%52-week change33.69P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated Common Stock128.96BMarket Cap+20.00%52-week change0.53P/E (Trailing)‪34.99%‬Profit Margin
- 0A45LSEModerna Inc.95.05BMarket Cap+87.31%52-week change72.95P/E (Trailing)‪11.32%‬Profit Margin
- 0QW0LSEargenx SE49.68BMarket Cap+27.60%52-week change40.07P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA41.70BMarket Cap-23.88%52-week change120.47P/E (Trailing)‪6.45%‬Profit Margin
- 0K91LSENorthern Trust Corporation37.94BMarket Cap+23.65%52-week change0.24P/E (Trailing)‪24.67%‬Profit Margin
Profile Summary - 0R2M - Regeneron Pharmaceuticals, Inc.
About
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, develops, manufactures, and commercializes medicines for people with serious diseases. Its portfolio spans treatments in eye care, immunology, oncology, cardiovascular and metabolic disease, infectious disease, hematology, and rare disorders.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
